Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
arsenic trioxide (trisenox) (2 trials)
decitabine (dacogen) (2 trials)
cytarabine (cytosar-u) (1 trial)
Leukemia (Phase 2)
Leukemia, Myeloid (Phase 2)
Leukemia, Myeloid, Acute (Phase 2)
Myelodysplastic Syndromes (Phase 3)
Preleukemia (Phase 3)
Syndrome (Phase 3)
Trials (2 total)
Trial APIs (3 total)